ProPharma Group (Linden Capital Portfolio) Acquires Southwood Research

Sole Source Capital Acquires Westwood Laboratories

October 17, 2022

Manufacturing

Sole Source Capital LLC, an industrial-focused private equity firm, has acquired Westwood Laboratories, a full-service contract manufacturer headquartered in Azusa, California that serves beauty, personal care, pet and over-the-counter drug brands. Five Points Capital provided unitranche debt and an equity co-invest to support the acquisition; terms were not disclosed.

ProPharma Group Acquires OneSource Regulatory and OneSource Regulatory Technology

August 23, 2022

Healthcare Services

ProPharma Group, a PE-backed provider of regulatory, clinical and compliance services, has acquired OneSource Regulatory and OneSource Regulatory Technology to expand its regulatory, medical and marketing operations services and technology capabilities. The deal brings OneSource’s regulatory consulting and promotional/labeling review expertise (headquartered in McKinney, Texas) into ProPharma’s global life sciences services platform; Edgemont Partners acted as exclusive financial advisor to OneSource.

ProPharma Group Acquires Pharmica Consulting

October 6, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.

ProPharma Group Acquires Diamond Pharma Services

March 2, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.

Odyssey Investment Partners Acquires ProPharma Group

September 22, 2020

Healthcare Services

Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.

ProPharma Group Acquires The Weinberg Group

January 28, 2019

Healthcare Services

ProPharma Group, a portfolio company of Linden Capital Partners, has acquired The Weinberg Group, a Washington, D.C.-based regulatory and compliance consultancy serving the pharmaceutical, biotech, and medical device industries. The deal expands ProPharma's pre-approval and pre-clinical regulatory capabilities and further integrates Weinberg's FDA-focused regulatory expertise into ProPharma's global life sciences compliance platform.